{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T16:33:41Z","timestamp":1785429221863,"version":"3.56.0"},"reference-count":54,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004329","name":"Slovenian Research and Innovation Agency","doi-asserted-by":"publisher","award":["P3-0326"],"award-info":[{"award-number":["P3-0326"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"award":["P3-0326"],"award-info":[{"award-number":["P3-0326"]}],"id":[{"id":"https:\/\/ror.org\/059bp8k51","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Background: The aim of our study was to evaluate the association of angiopoietin 2 (ANGPT2) rs2442598 and vascular endothelial growth factor A (VEGFA) rs2010963 with diabetic nephropathy (DN) in Slovenian subjects with type 2 diabetes mellitus (T2DM). Angiopoietin\u2013endothelial tyrosine kinase receptor (Ang-Tie2) and VEGF-A signaling regulate glomerular endothelial stability and permeability and may contribute to DN susceptibility. Methods: We conducted a case\u2013control study including 897 unrelated Slovenian subjects with T2DM (344 DN cases; 553 long-standing T2DM controls without DN). ANGPT2 rs2442598 and VEGFA rs2010963 were genotyped using TaqMan assays. Genetic associations were analysed using co-dominant, additive, dominant, and recessive genetic models with logistic regression adjusted for waist circumference, systolic blood pressure, fasting glucose, and triglycerides. Results:\u00a0ANGPT2 rs2442598 was significantly associated with DN, with increased risk in carriers of the C allele, including a significant additive per allele effect (OR 1.39, 95% CI 1.10\u20131.74) and a dominant model effect (OR 1.47, 95% CI 1.11\u20131.96). In contrast, VEGFA rs2010963 showed no evidence of association across genetic models. Conclusions: In Slovenian patients with T2DM, ANGPT2 rs2442598 is associated with DN, whereas VEGFA rs2010963 is not. This association suggests that ANGPT2 genetic variation may influence DN risk and supports further functional work to define the biological effects of rs2442598.<\/jats:p>","DOI":"10.3390\/genes17040373","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T15:34:27Z","timestamp":1774452867000},"page":"373","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association Between the ANGPT2 rs2442598 Polymorphism and Diabetic Nephropathy in Slovenian Patients with Type 2 Diabetes Mellitus"],"prefix":"10.3390","volume":"17","author":[{"given":"Petra","family":"Nussdorfer","sequence":"first","affiliation":[{"name":"Laboratory for Histology and Genetics of Atherosclerosis and Microvascular Diseases, Faculty of Medicine, University of Ljubljana, Korytkova 2, 1000 Ljubljana, Slovenia"},{"name":"Institute of Histology and Embryology, Faculty of Medicine, University of Ljubljana, Korytkova 2, 1000 Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1473-3534","authenticated-orcid":false,"given":"Jernej","family":"Letonja","sequence":"additional","affiliation":[{"name":"Laboratory for Histology and Genetics of Atherosclerosis and Microvascular Diseases, Faculty of Medicine, University of Ljubljana, Korytkova 2, 1000 Ljubljana, Slovenia"},{"name":"Institute of Histology and Embryology, Faculty of Medicine, University of Ljubljana, Korytkova 2, 1000 Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matej","family":"Zavr\u0161nik","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetology, Internal Medicine Clinic, University Clinical Center, 2000 Maribor, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo\u0161tjan","family":"Matos","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Clinical Center, 1000 Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danijel","family":"Petrovi\u010d","sequence":"additional","affiliation":[{"name":"Laboratory for Histology and Genetics of Atherosclerosis and Microvascular Diseases, Faculty of Medicine, University of Ljubljana, Korytkova 2, 1000 Ljubljana, Slovenia"},{"name":"Institute of Histology and Embryology, Faculty of Medicine, University of Ljubljana, Korytkova 2, 1000 Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Cilen\u0161ek","sequence":"additional","affiliation":[{"name":"Laboratory for Histology and Genetics of Atherosclerosis and Microvascular Diseases, Faculty of Medicine, University of Ljubljana, Korytkova 2, 1000 Ljubljana, Slovenia"},{"name":"Institute of Histology and Embryology, Faculty of Medicine, University of Ljubljana, Korytkova 2, 1000 Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_2","unstructured":"Sapra, A., and Bhandari, P. (2026, February 02). Diabetes, StatPearls (Internet), Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK551501\/."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s13098-023-01202-x","article-title":"Prevalence and predictors of chronic kidney disease among type 2 diabetic patients worldwide, systematic review and meta-analysis","volume":"15","author":"Fenta","year":"2023","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1524-6175.2004.02524.x","article-title":"Microalbuminuria in type 2 diabetics: An important, overlooked cardiovascular risk factor","volume":"6","author":"Weir","year":"2004","journal-title":"J. Clin. Hypertens"},{"key":"ref_5","unstructured":"International Diabetes Federation (2025). IDF Diabetes Atlas, International Diabetes Federation. [11th ed.]. Available online: https:\/\/diabetesatlas.org\/resources\/idf-diabetes-atlas-2025\/."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.2337\/diacare.27.6.1330","article-title":"Reduced mortality associated with the use of ACE inhibitors in patients with type 2 diabetes","volume":"27","author":"Eurich","year":"2004","journal-title":"Diabetes Care"},{"key":"ref_7","first-page":"29","article-title":"Polymorphism of angiotensin-converting enzyme (rs4340) and diabetic nephropathy in Caucasians with type 2 diabetes mellitus","volume":"19","author":"Makuc","year":"2017","journal-title":"Balk. J. Med. Genet."},{"key":"ref_8","unstructured":"Zavr\u0161nik, M. (2019). Polymorphisms of Inflammatory Genes as Potential Predictors of Diabetic Nephropathy in Patients with Type 2 Diabetes. [Ph.D. Thesis, University of Zagreb School of Medicine]. Available online: https:\/\/urn.nsk.hr\/urn:nbn:hr:105:426338."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1523-1755.2003.00712.x","article-title":"Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64)","volume":"63","author":"Adler","year":"2003","journal-title":"Kidney Int."},{"key":"ref_10","first-page":"347","article-title":"Interleukin-4 (IL4)-590C\/T (rs2243250) gene polymorphism is not associated with diabetic nephropathy (DN) in Caucasians with type 2 diabetes mellitus (T2DM)","volume":"18","author":"Letonja","year":"2018","journal-title":"Bosn. J. Basic Med. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee (2024). Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes\u20142024. Diabetes Care, 47, S219\u2013S230.","DOI":"10.2337\/dc24-S011"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"(2024). Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int., 105, S117\u2013S314.","DOI":"10.1016\/j.kint.2023.10.018"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.2337\/diabetes.54.10.2983","article-title":"Factors associated with frequent remission of microalbuminuria in patients with type 2 diabetes","volume":"54","author":"Araki","year":"2005","journal-title":"Diabetes"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"21501319241259325","DOI":"10.1177\/21501319241259325","article-title":"Prevalence of Chronic Kidney Disease in Individuals with Type 2 Diabetes Within Primary Care: A Cross-Sectional Study","volume":"15","year":"2024","journal-title":"J. Prim. Care Community Health"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"An, D.Y., Tan, J., Lu, Y.D., Wen, Z.H., Bao, Y.N., Yao, Z.H., Chen, Z.Y., Wang, P.P., Zhou, W., and Yang, Q. (2024). Focus on podocytes: Diabetic kidney disease and renal fibrosis-a global bibliometric analysis (2000\u20132024). Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1454586"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.semnephrol.2007.01.012","article-title":"Histopathology of diabetic nephropathy","volume":"27","author":"Fioretto","year":"2007","journal-title":"Semin. Nephrol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Kataoka, H., Nitta, K., and Hoshino, J. (2023). Glomerular hyperfiltration and hypertrophy: An evaluation of maximum values in pathological indicators to discriminate diseased from normal. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1179834"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1007\/s00125-016-3995-3","article-title":"Angiopoietins and diabetic nephropathy","volume":"59","author":"Gnudi","year":"2016","journal-title":"Diabetologia"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.2337\/db22-0169","article-title":"Multi-Scalar Data Integration Links Glomerular Angiopoietin-Tie Signaling Pathway Activation with Progression of Diabetic Kidney Disease","volume":"71","author":"Liu","year":"2022","journal-title":"Diabetes"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"a006550","DOI":"10.1101\/cshperspect.a006650","article-title":"The complex role of angiopoietin-2 in the angiopoietin-tie signaling pathway","volume":"2","author":"Thurston","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/74725","article-title":"Angiopoietin-1 protects the adult vasculature against plasma leakage","volume":"6","author":"Thurston","year":"2000","journal-title":"Nat. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1128\/MCB.01472-08","article-title":"Angiopoietin 2 is a partial agonist\/antagonist of Tie2 signaling in the endothelium","volume":"29","author":"Yuan","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.kint.2022.06.026","article-title":"Angiopoietin-2 inhibition attenuates kidney fibrosis by hindering chemokine C-C motif ligand 2 expression and apoptosis of endothelial cells","volume":"102","author":"Chang","year":"2022","journal-title":"Kidney Int."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1172\/JCI58832","article-title":"Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling","volume":"122","author":"Felcht","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"163120","DOI":"10.1155\/2015\/163120","article-title":"Urinary angiopoietin-2 is associated with albuminuria in patients with type 2 diabetes mellitus","volume":"2015","author":"Chen","year":"2015","journal-title":"Int. J. Endocrinol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.omtn.2018.10.003","article-title":"Angpt2 Induces Mesangial Cell Apoptosis through the MicroRNA-33-5p-SOCS5 Loop in Diabetic Nephropathy","volume":"13","author":"Tsai","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_27","unstructured":"National Center for Biotechnology Information (NCBI) (2025, December 18). Gene: ANGPT2 Angiopoietin 2 (Homo sapiens). NCBI Gene; Gene ID: 285, Available online: https:\/\/www.ncbi.nlm.nih.gov\/gene\/285."},{"key":"ref_28","first-page":"794","article-title":"The rs2442598 polymorphism in the ANGPT-2 gene is associated with risk for diabetic retinopathy in patients with type 1 diabetes mellitus in a Brazilian population","volume":"65","author":"Dieter","year":"2021","journal-title":"Arch. Endocrinol. Metab."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"622","DOI":"10.34172\/aim.2021.88","article-title":"Association between Angiopoietin-2 Gene Polymorphisms and Susceptibility to Coronary Artery Disease","volume":"24","author":"Lan","year":"2021","journal-title":"Arch. Iran. Med."},{"key":"ref_30","first-page":"16121","article-title":"Preliminary observations on ANGPT1 and ANGPT2 polymorphisms in systemic sclerosis: ANGPT2 rs2442598 and rs3739390 are associated with disease susceptibility and diffuse disease subtype","volume":"131","author":"Rusek","year":"2021","journal-title":"Pol. Arch. Intern. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1164\/rccm.201005-0701OC","article-title":"ANGPT2 genetic variant is associated with trauma-associated acute lung injury and altered plasma angiopoietin-2 isoform ratio","volume":"183","author":"Meyer","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"97","DOI":"10.7150\/ijms.37675","article-title":"Angiopoietin-2 gene polymorphisms are biomarkers for the development and progression of colorectal cancer in Han Chinese","volume":"17","author":"Du","year":"2020","journal-title":"Int. J. Med. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41580-023-00631-w","article-title":"Biology and therapeutic targeting of vascular endothelial growth factor A","volume":"24","author":"Ferrara","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_34","unstructured":"National Center for Biotechnology Information (NCBI) (2025, November 27). Gene: VEGFA Vascular Endothelial Growth Factor A (Homo sapiens). NCBI Gene; Gene ID: 7422, Available online: https:\/\/www.ncbi.nlm.nih.gov\/gene\/7422."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"805801","DOI":"10.1155\/2014\/805801","article-title":"The associations between VEGF gene polymorphisms and diabetic retinopathy susceptibility: A meta-analysis of 11 case-control studies","volume":"2014","author":"Han","year":"2014","journal-title":"J. Diabetes Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.gene.2013.01.018","article-title":"VEGF-634G>C polymorphism and diabetic retinopathy risk: A meta-analysis","volume":"518","author":"Qiu","year":"2013","journal-title":"Gene"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1089\/gtmb.2018.0320","article-title":"Associations Between Genetic Polymorphisms in the VEGFA, ACE, and SOD2 Genes and Susceptibility to Diabetic Nephropathy in the Han Chinese","volume":"23","author":"Luo","year":"2019","journal-title":"Genet. Test. Mol. Biomark."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.2337\/diabetes.51.5.1635","article-title":"A common polymorphism in the 5\u2032-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes","volume":"51","author":"Awata","year":"2002","journal-title":"Diabetes"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Lu, Y., Ge, Y., Shi, Y., Yin, J., and Huang, Z. (2013). Two polymorphisms (rs699947, rs2010963) in the VEGFA gene and diabetic retinopathy: An updated meta-analysis. BMC Ophthalmol., 13.","DOI":"10.1186\/1471-2415-13-56"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"773","DOI":"10.25259\/IJN_10_2025","article-title":"The Association between Single Nucleotide Polymorphisms in SIRT1 and ANGPT2 Genes and End-Stage Kidney Disease","volume":"35","author":"Badr","year":"2025","journal-title":"Indian J. Nephrol."},{"key":"ref_41","first-page":"72","article-title":"Association of 1233A\/G polymorphism of angiopoietin-2 gene with type 2 diabetes mellitus and diabetic nephropathy","volume":"29","author":"He","year":"2012","journal-title":"Chin. J. Med. Genet."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.dsx.2019.03.016","article-title":"Study of Angiopoietin-2 and vascular endothelial growth factor as markers of diabetic nephropathy onset in Egyptians diabetic patients with non-albuminuric state","volume":"13","author":"Aly","year":"2019","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Alshawaf, E., Abu-Farha, M., Mohammad, A., Devarajan, S., Al-Khairi, I., Cherian, P., Ali, H., Al-Matrouk, H., Al-Mulla, F., and Al Attar, A. (2024). Angiopoietin-2 and Angiopoietin-like Proteins with a Prospective Role in Predicting Diabetic Nephropathy. Biomedicines, 12.","DOI":"10.3390\/biomedicines12050949"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1007\/s00431-024-05637-w","article-title":"Serum angiopoietin-2: A promising biomarker for early diabetic kidney disease in children and adolescents with type 1 diabetes","volume":"183","author":"Salem","year":"2024","journal-title":"Eur. J. Pediatr."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s11033-011-0812-4","article-title":"The role of vascular endothelial growth factor +405 G\/C polymorphism and albuminuria in patients with type 2 diabetes mellitus","volume":"39","author":"Nikzamir","year":"2012","journal-title":"Mol. Biol. Rep."},{"key":"ref_46","first-page":"421","article-title":"Blood Glucose, HbA1c Level, and its Correlation with VEGFA (+405G\/C) Polymorphism as Biomarker Predicts the Risk of Retinopathy and Nephropathy in Type 2 Diabetic Patients","volume":"11","author":"Ibrahim","year":"2022","journal-title":"Rep. Biochem. Mol. Biol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"6411","DOI":"10.1167\/iovs.12-9727","article-title":"The C Allele of -634G\/C polymorphism in the VEGFA gene is associated with increased VEGFA gene expression in human retinal tissue","volume":"53","author":"Vailati","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Grbi\u0107, E., Letonja, J., and Petrovi\u010d, D. (2024). The VEGFA rs2010963 Gene Polymorphism Is a Potential Genetic Risk Factor for Myocardial Infarction in Slovenian Subjects with Type 2 Diabetes Mellitus. Biomolecules, 14.","DOI":"10.3390\/biom14121584"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"30539","DOI":"10.18632\/oncotarget.15546","article-title":"Vascular endothelial growth factor A polymorphisms are associated with increased risk of coronary heart disease: A meta-analysis","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Nazir, N., Siddiqui, K., Al-Qasim, S., and Al-Naqeb, D. (2014). Meta-analysis of diabetic nephropathy associated genetic variants in inflammation and angiogenesis involved in different biochemical pathways. BMC Med. Genet., 15.","DOI":"10.1186\/s12881-014-0103-8"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Nussdorfer, P., Petrovi\u010d, D., Alibegovi\u0107, A., Cilen\u0161ek, I., and Petrovi\u010d, D. (2024). The KDR Gene rs2071559 and the VEGF Gene rs6921438 May Be Associated with Diabetic Nephropathy in Caucasians with Type 2 Diabetes Mellitus. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25179439"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.2337\/DB11-1655","article-title":"VEGFA protects the glomerular microvasculature in diabetes","volume":"61","author":"Sivaskandarajah","year":"2012","journal-title":"Diabetes"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.semnephrol.2012.06.010","article-title":"VEGF and podocytes in diabetic nephropathy","volume":"32","author":"Tufro","year":"2012","journal-title":"Semin. Nephrol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1681\/ASN.2006101093","article-title":"Podocyte-specific expression of angiopoietin-2 causes proteinuria and apoptosis of glomerular endothelia","volume":"18","author":"Davis","year":"2007","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/17\/4\/373\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T15:59:36Z","timestamp":1775059176000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/17\/4\/373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":54,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["genes17040373"],"URL":"https:\/\/doi.org\/10.3390\/genes17040373","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]}}}